Nerve Stimulation for Parkinson's Disease

This trial tests whether a gentle nerve stimulation technique, transcutaneous auricular vagus nerve stimulation (taVNS), can help people with Parkinson's Disease manage heart rate and blood pressure issues. These problems often hinder exercise and daily activities. The trial aims to determine if this non-invasive method can support physical therapy and improve overall function. Participants will switch between real and sham (inactive) treatments in two groups. People with Parkinson's who have maintained a stable medication routine for at least four weeks might be suitable candidates. As an unphased trial, this study provides a unique opportunity to explore innovative treatments that could enhance daily living for Parkinson's patients.

You need to have stable medication for at least 4 weeks before joining the study, but you cannot use beta blockers. The trial does not specify if you need to stop other medications.

Research has shown that transcutaneous auricular Vagus Nerve Stimulation (taVNS), a device used to gently stimulate the ear, is generally safe for people with Parkinson's Disease. Studies have found some minor side effects, but no serious problems have been linked to taVNS. Most participants tolerated this treatment well, handling it without major issues. Overall, based on past research, taVNS appears to be a safe option.¹²³⁴⁵

Researchers are excited about transcutaneous auricular vagus nerve stimulation (taVNS) for Parkinson's disease because it offers a non-invasive and targeted approach to treatment. Unlike standard therapies that often involve medications or deep brain stimulation, taVNS stimulates the vagus nerve through the ear, potentially reducing symptoms with fewer side effects. This method is unique because it could modulate brain activity without surgery, offering a new avenue for symptom management that is less intrusive and more accessible.

Research has shown that transcutaneous auricular vagus nerve stimulation (taVNS) might benefit people with Parkinson's Disease. Studies have found that taVNS can enhance movement and coordination, as well as non-motor symptoms like sleep and overall quality of life. It may also help manage heart rate and blood pressure, common issues for those with Parkinson's. Some research suggests that taVNS could enhance the effectiveness of physical therapy by improving the body's response during exercise. In this trial, participants will receive either active taVNS or sham taVNS to evaluate its effectiveness. While the results are promising, improvements in walking have been modest.¹²³⁴⁶